2FLD image
Deposition Date 2006-01-05
Release Date 2006-06-06
Last Version Date 2023-08-30
Entry Detail
PDB ID:
2FLD
Keywords:
Title:
I-MsoI Re-Designed for Altered DNA Cleavage Specificity
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.27
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:DNA ENDONUCLEASE I-MSOI
Chain IDs:C (auth: A), D (auth: B)
Chain Length:165
Number of Molecules:2
Biological Source:Monomastix sp.
Primary Citation
Computational redesign of endonuclease DNA binding and cleavage specificity.
Nature 441 656 659 (2006)
PMID: 16738662 DOI: 10.1038/nature04818

Abstact

The reprogramming of DNA-binding specificity is an important challenge for computational protein design that tests current understanding of protein-DNA recognition, and has considerable practical relevance for biotechnology and medicine. Here we describe the computational redesign of the cleavage specificity of the intron-encoded homing endonuclease I-MsoI using a physically realistic atomic-level forcefield. Using an in silico screen, we identified single base-pair substitutions predicted to disrupt binding by the wild-type enzyme, and then optimized the identities and conformations of clusters of amino acids around each of these unfavourable substitutions using Monte Carlo sampling. A redesigned enzyme that was predicted to display altered target site specificity, while maintaining wild-type binding affinity, was experimentally characterized. The redesigned enzyme binds and cleaves the redesigned recognition site approximately 10,000 times more effectively than does the wild-type enzyme, with a level of target discrimination comparable to the original endonuclease. Determination of the structure of the redesigned nuclease-recognition site complex by X-ray crystallography confirms the accuracy of the computationally predicted interface. These results suggest that computational protein design methods can have an important role in the creation of novel highly specific endonucleases for gene therapy and other applications.

Legend

Protein

Chemical

Disease

Primary Citation of related structures